These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1705580)

  • 1. A cost-minimization study of cancer patients requiring a narcotic infusion in hospital and at home.
    Ferris FD; Wodinsky HB; Kerr IG; Sone M; Hume S; Coons C
    J Clin Epidemiol; 1991; 44(3):313-27. PubMed ID: 1705580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Societal costs of home and hospital end-of-life care for palliative care patients in Ontario, Canada.
    Yu M; Guerriere DN; Coyte PC
    Health Soc Care Community; 2015 Nov; 23(6):605-18. PubMed ID: 25443659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcutaneous narcotic infusions for cancer pain: treatment outcome and guidelines for use.
    Moulin DE; Johnson NG; Murray-Parsons N; Geoghegan MF; Goodwin VA; Chester MA
    CMAJ; 1992 Mar; 146(6):891-7. PubMed ID: 1371946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costs associated with resource utilization during the palliative phase of care: a Canadian perspective.
    Dumont S; Jacobs P; Fassbender K; Anderson D; Turcotte V; Harel F
    Palliat Med; 2009 Dec; 23(8):708-17. PubMed ID: 19837702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative cost analysis of home and hospital treatment.
    Vinciguerra V; Degnan TJ; Budman DR; Brody RS; Moore T; Sciortino A; O'Connell M
    Prog Clin Biol Res; 1986; 216():155-64. PubMed ID: 2425371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of resources and costs of palliative care with parenteral fluids and analgesics in the home setting for patients with end-stage cancer.
    Witteveen PO; van Groenestijn MA; Blijham GH; Schrijvers AJ
    Ann Oncol; 1999 Feb; 10(2):161-5. PubMed ID: 10093684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous opioid infusions at home.
    Coyle N; Cherny NI; Portenoy RK
    Oncology (Williston Park); 1994 Apr; 8(4):21-7; discussion 31-2, 37. PubMed ID: 8003396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic analysis of home vs hospital-based parenteral nutrition in Ontario, Canada.
    Marshall JK; Gadowsky SL; Childs A; Armstrong D
    JPEN J Parenter Enteral Nutr; 2005; 29(4):266-9. PubMed ID: 15961683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home palliative care as a cost-saving alternative: evidence from Catalonia.
    Serra-Prat M; Gallo P; Picaza JM
    Palliat Med; 2001 Jul; 15(4):271-8. PubMed ID: 12054144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of home palliative care compared with conventional hospital care for patients with haematological cancers in Greece.
    Tzala S; Lord J; Ziras N; Repousis P; Potamianou A; Tzala E
    Eur J Health Econ; 2005 Jun; 6(2):102-6. PubMed ID: 19787846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of the subcutaneous route for the administration of narcotics in patients with cancer pain.
    Bruera E; Brenneis C; Michaud M; Bacovsky R; Chadwick S; Emeno A; MacDonald N
    Cancer; 1988 Jul; 62(2):407-11. PubMed ID: 2454724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective.
    Wai AO; Frighetto L; Marra CA; Chan E; Jewesson PJ
    Pharmacoeconomics; 2000 Nov; 18(5):451-7. PubMed ID: 11151398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brief courses of palliative radiotherapy for metastatic bone pain: a pilot cost-minimization comparison with narcotic analgesics.
    Macklis RM; Cornelli H; Lasher J
    Am J Clin Oncol; 1998 Dec; 21(6):617-22. PubMed ID: 9856668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraspinal narcotic infusions for terminal cancer pain.
    St Marie B; Henrickson K
    J Intraven Nurs; 1988; 11(3):161-3. PubMed ID: 3373362
    [No Abstract]   [Full Text] [Related]  

  • 15. A randomized controlled trial of the cost-effectiveness of a district co-ordinating service for terminally ill cancer patients.
    Raftery JP; Addington-Hall JM; MacDonald LD; Anderson HR; Bland JM; Chamberlain J; Freeling P
    Palliat Med; 1996 Apr; 10(2):151-61. PubMed ID: 8800823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of home infusion therapy on the Colorado Medicaid program budget.
    Culbertson VL; Rhodes RS; Hill EP; Rhodes PJ
    Am J Hosp Pharm; 1988 Jun; 45(6):1346-9. PubMed ID: 3137814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. End-of-Life Care Interventions: An Economic Analysis.
    Pham B; Krahn M
    Ont Health Technol Assess Ser; 2014; 14(18):1-70. PubMed ID: 26339303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of a transitional home-based palliative care program for patients with end-stage heart failure.
    Wong FKY; So C; Ng AYM; Lam PT; Ng JSC; Ng NHY; Chau J; Sham MMK
    Palliat Med; 2018 Feb; 32(2):476-484. PubMed ID: 28434275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost savings in hospice: final results of the National Hospice Study.
    Mor V; Kidder D
    Health Serv Res; 1985 Oct; 20(4):407-22. PubMed ID: 4055382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of an expanding home care program for the terminally ill.
    McCusker J; Stoddard AM
    Med Care; 1987 May; 25(5):373-85. PubMed ID: 3695652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.